PB CPD Online e-learning site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (1998) 22: 605-607. doi: 10.1192/pb.22.10.605
© 1998 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, J. C.
Right arrow Articles by Thomas, C. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jones, J. C.
Right arrow Articles by Thomas, C. S.

Investigation of depot neuroleptic injection site reactions

Julie C. Jones

Department of Psychiatry, University Hospital of South Manchester, Manchester

Jennifer C. Day

Department of Pharmaceutical Sciences, University of Nottingham, Nottingham

John R. Taylor

North Mersey Community Trust, Sefton General Hospital, Liverpool

Christopher S. Thomas*

Department of Psychiatry, University Hospital of South Manchester, Nell Lane, Manchester M20 8LR

* Correspondence

Aims and method A cross-sectional survey was performed on 318 patients receiving depot medication. The presence or absence of a depot site reaction was recorded by psychiatric nursing staff on a standardised form.

Results Seventeen per cent of patients were found to have clinically significant depot site reactions. Such reactions were associated with increased frequency of injection and increased total volume of depot administered in the previous 12 months. The severity of a depot site reaction was unrelated to the concentration of depot preparation administered.

Clinical implications Depot site reactions may be reduced by maximising the interval between injections and using low volume (highly concentrated) preparations of depot neuroleptic medication.




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
C. Paton, R. Duffett, M. Harrington, P. Lelliott, C. Okocha, and T. Sensky
Patterns of Antipsychotic and Anticholinergic Prescribing for Hospital Inpatients
J Psychopharmacol, June 1, 2003; 17(2): 223 - 229.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1998 The Royal College of Psychiatrists.